Safety and efficacy of ibutilide in heart transplant recipients.

Academic Article


  • In this report we describe our experience with ibutilide, a relatively new Class III anti-arrhythmic agent, in 8 heart transplant patients with supraventricular tachycardia in various settings (3 patients with rejection, 2 after endomyocardial biopsy). Ibutilide treatment was successful in all patients, with the arrhythmia recurring early in 1 patient. There were no complications.
  • Published In


  • Adolescent, Adult, Anti-Arrhythmia Agents, Atrial Fibrillation, Atrial Flutter, Atrioventricular Block, Biopsy, Electrocardiography, Endocardium, Female, Graft Rejection, Heart Transplantation, Humans, Infusions, Intravenous, Male, Middle Aged, Myocardium, Postoperative Complications, Sulfonamides, Tachycardia, Supraventricular, Treatment Outcome
  • Digital Object Identifier (doi)

    Author List

  • Tallaj JA; Franco V; Rayburn BK; Pamboukian SV; Benza RL; Kirklin JK; McGiffin DC; Smallfield M; Bourge RC
  • Start Page

  • 505
  • End Page

  • 507
  • Volume

  • 28
  • Issue

  • 5